Live Rankings Top Stocks Top Influencers

Track retail momentum on X with live rankings, 30-day stock signals, and the voices driving the conversation.

Follow us on X Day Trade Edge ↗

Explore

Live Ranking Top Stocks (30D)Top Influencers

Learn

About Olyth How It Works Terms of Use Privacy Policy

© Olyth. All rights reserved.

Oculis Holding AG Warrants ($OCSAW) Stock Price, Chart & Sentiment on X | Olyth

Live Rankings/Top Stocks/OCSAW

OCSAW

Oculis Holding AG Warrants

Near 52W Low

$4.79+$0.00 (+0.00%)

Loading Chart...

Live Ranking Top Influencers Top Stocks (30D)

Institutional Signal // Day Trade Edge:Neutral / No Active Setup Today

Scan Active Universe on Day Trade Edge

Key Statistics

Market Cap—

Forward P/E—

EPS (TTM)—

52-Week Return—

50-Day Moving Avg—

200-Day Moving Avg—

Volume Today9.13K

Avg Volume9.13K

Day Range$4.46 – $5.48

52-Week Range$4.46 – $5.48

Open Price$9.91

Previous Close$4.79

Company Profile

Recent News

Company Profile

No profile description available.

SEC Filings

Exchange Listing

Recent News

MT Newswires8/24/2026

Oculis Treats First Patient in Optic Neuritis Trial; Shares Up Pre-Bell

GlobeNewswire8/24/2026

First Patient Treated in PIONEER-1 Registrational Trial of Privosegtor for Optic Neuritis

GlobeNewswire8/14/2026

Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities

Does Oculis Holding AG (OCS) Have the Potential to Rally 187.83% as Wall Street Analysts Expect?

MT Newswires8/10/2026

Oculis to Buy Accure's Global Development, Commercial Rights to Privosegtor

GlobeNewswire8/10/2026

Oculis Signs Asset Purchase Agreement with Accure Therapeutics for Lead Candidate, Privosegtor, Fortifying Oculis’ Position as an Emerging Leading Neuro-Ophthalmology Company

Oculis Holding AG (OCS) Reports Q2 Loss, Tops Revenue Estimates

GlobeNewswire8/6/2026

Oculis Reports Q2 2026 Financial Results and Provides Company Update